Susquehanna International Group
PAVM icon

Susquehanna International Group’s PAVmed PAVM Stock Holding History

Susquehanna International Group’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-41
Closed -$16K – 13341
2022
Q3 		$16K Sell
41
-44
-52% -$24.9K ﹤0.01% 12674
2022
Q2 		$35K Sell
85
-99
-54% -$47.8K ﹤0.01% 12152
2022
Q1 		$109K Sell
184
-62
-25% -$46.1K ﹤0.01% 11846
2021
Q4 		$273K Buy
246
+84
+52% +$183K ﹤0.01% 10706
2021
Q3 		$621K Buy
162
+66
+69% +$208K ﹤0.01% 8831
2021
Q2 		$276K Sell
96
-72
-43% -$170K ﹤0.01% 10957
2021
Q1 		$335K Buy
+168
New +$253K ﹤0.01% 10374

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's PAVM Position: Q1 2026 in Review

Susquehanna International Group sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 2,274 shares — an estimated $15.1K sold.

Susquehanna International Group first reported a position in PAVM in Q1 2018 and held it in 14 quarters. The position peaked at $1.2M in Q1 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Susquehanna International Group reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 2,274 PAVmed shares in Q1 2026, an estimated $15.1K.
  • Susquehanna International Group first reported a position in PAVmed in Q1 2018 and held it in 14 quarters.
  • Susquehanna International Group's PAVmed position peaked at $1.2M in Q1 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.